Using multiple different approaches, they were able to reproducibly generate 3 meningioma DNA methylation groups that showed significant differences in clinical outcome and biology: Merlin-intact (MI), immune-enriched (IE), and hypermitotic (HM). This evidence concerns the gene NF2 and meningioma.